The US National Institutes of Health announced the Standardized Organoid Modeling Center with $87 million in funding over three years to establish reproducible, scalable organoid research protocols. This initiative responds to FDA and biopharma industry calls to reduce reliance on animal models during preclinical development. The center aims to accelerate adoption of organoid platforms, improving translational fidelity and ethical considerations in drug discovery and personalized medicine applications.